Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Kevin Stansfield has worked on the following 15 EPO patent applications which have been published in the last five years:

EP14179976

PARP inhibitor compounds, compositions and methods of use

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/06, C07D 519/00
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12700259

FUSED AMINODIHYDROTHIAZINE DERIVATIVES

IPC classification:
A61K 31/542, A61P 25/28, C07D 279/08, C07D 513/04
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Multiple attorneys, Eisai Europe Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15159875

Intermediates for the preparation of halichondrin B

IPC classification:
C07D 307/28, C07D 307/33, C07D 493/08, C07D 493/18, C07F 7/18
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
EXAMINATION IN PROGRESS
EP12703573

FUSED AMINODIHYDROTHIAZINE DERIVATIVES

IPC classification:
A61P 25/28, C07D 513/04
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13176232

Fused Aminodihydro-Oxazine Derivatives

IPC classification:
A61K 31/5365, A61P 25/28, C07D 498/04
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14799529

4-AZAINDOLE DERIVATIVES

IPC classification:
A61K 31/437, A61P 25/00, C07D 471/04
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
EXAMINATION IN PROGRESS
EP14790956

PYRIMIDINE FGFR4 INHIBITORS

IPC classification:
A61K 31/505, A61P 35/00, C07D 239/48, C07D 405/12, C07D 413/12
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
EXAMINATION IN PROGRESS
EP14790936

SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS

IPC classification:
A61K 31/4545, A61P 37/00, C07D 401/04
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
GRANT OF PATENT INTENDED
EP14790937

SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS

IPC classification:
A61K 31/47, A61K 31/535, A61P 37/00, C07D 403/14, C07D 413/04, C07D 413/14
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
GRANT OF PATENT INTENDED
EP14858240

MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B

IPC classification:
C07C 6/02, C07D 307/28, C07D 493/22
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
EXAMINATION REQUESTED
EP12708716

FUSED AMINODIHYDROTHIAZINE DERIVATIVES USEFUL AS BACE INHIBITORS

IPC classification:
A61K 31/542, A61P 3/00, A61P 25/00, C07D 513/04
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
PATENT GRANTED
EP12191294

Intermediates for the synthesis of halichondrin B analogs

IPC classification:
C07D 307/28, C07D 307/33, C07D 493/08, C07D 493/18
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14866945

METHODS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS

IPC classification:
C07D 491/22
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
EXAMINATION REQUESTED
EP11702900

FURO[3,2-B]PYRANE DERIVATIVES USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS

IPC classification:
C07D 405/06, C07D 405/12, C07D 493/04
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Celia Mary Keen, J A Kemp
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15727125

PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS OF USE

IPC classification:
A61P 35/00, C07D 405/06
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Kevin Stansfield, Eisai Europe Ltd
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature